AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
GLYCOPYRRONIUM BROMIDE
11 registrations across 6 African markets— 10 active
Markets with GLYCOPYRRONIUM BROMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Glycopyrronium Bromide 200 micrograms per ml Solution for Injection Solution for Injection | 🇿🇲Zambia | Macarthys Laboratories Limited T/A Martindale Pharma | active | May 2029 |
| GLYCOPYRRONIUM BROMIDE SOLUTION; INJECTION | 🇿🇼Zimbabwe | MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA | active | May 2029 |
| CHOLSTYQ | 🇿🇦South Africa | Umsebe Healthcare | active | May 2027 |
| SEEBRI BREEZHALER Poudre pour inhalation buccale / 44µg | 🇹🇳Tunisia | NOVARTIS EUROPHARM LIMITED IRLANDE | expired | Mar 2021 |
| GLYCOPYRROLATE 0,2 mg/1 ml FRESENIUS | 🇿🇦South Africa | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | Jan 1900 |
| ROBINUL 2 ml INJECTABLE | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| GLYCOPYRROLATE 0,4 mg/2 ml FRESENIUS | 🇿🇦South Africa | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | Jan 1900 |
| ROBINUL 1 ml INJECTABLE | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| GLYCOPYRRONIUM
BROMIDE PARENTERAL
ORDINARY
AMPOULES | 🇺🇬Uganda | MACARTHYS LABORATORIES | active | — |
| Glycopyrronium Bromide Solution for injection | 🇹🇿Tanzania | MARTINDALE PHARMA | active | — |
| GLYCOPYRRONIUM
BROMIDE PARENTERAL
ORDINARY
AMPOULES | 🇺🇬Uganda | MACARTHYS LABORATORIES | active | — |
GLYCOPYRRONIUM BROMIDE in Africa — Regulatory Overview
GLYCOPYRRONIUM BROMIDE is registered across 6 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Tunisia, Tanzania and 2 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 10 (91%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.